The US Food and Drug Administration today approved for the first time a marijuana-derived drug, Epidiolex, for the treatment of two rare forms of epilepsy. The drug contains cannabidiol, or CBD, and does not make users high while reducing the rate of seizures in patients with Dravet or Lennox-Gastaut syndromes, clinical trials show. “In my
Marijuana law reform has been in the air lately. Last November, Colorado and Washington voted to legalize recreational weed use in their states, and Illinois recently became the latest state to legalize the drug for use as a medicine. In a speech at the American Bar Association’s annual meeting this month, US Attorney General Eric
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore mag na aliquam Lorem ipsum dolor sit amet…
A major safety concern associated with medical cannabis is the possibility of medical use encouraging or transitioning into recreational use, which is associated with side effects that range from acute to chronic. Acute effects include intoxication, impaired cognition and motor function, elevated heart rate, anxiety, and psychosis in predisposed individuals. Chronic effects include bronchitis (from